Focusing on cancer

TMRC is a biopharmaceutical company, specializing in the development of innovative anti-cancer products and those for cancer associated disorders with a particular focus on unmet medical needs area. TMRC has excellent capabilities and substantial resources for developing its own drug candidates as well as licensed-in products to which we add high value through obtaining clinical proof of concept (POC) or showing clear-cut possibilities for additional indications or for new formulations.

In expanding development pipeline, TMRC continues to seek to license-in or to acquire either preclinical or clinical stage drug candidates from other pharmaceutical industries and academic institutions worldwide. TMRC has established a strong and closed network with outside oncology experts for the evaluation of license-in candidates.

TMRC routinely reviews and determines the best development and commercialization strategy for each product in order to deliver rapidly safe and effective pharmaceuticals to patients suffering from serious cancers.

Business correlation chart